2-[2-(1-benzothiophen-3-yl)ethyl]-3-methoxyquinoxaline;8-chloro-4-methoxy-7-methyl-2-(trifluoromethyl)quinazoline;2,3-dimethoxyquinoxaline;2-(3,5-dimethylpyrazol-1-yl)-3-methoxyquinoxaline;2-methoxy-3-[(4-methylpiperazin-1-yl)methyl]quinoxaline;2-methoxy-3-(2-phenylethyl)quinoxaline;2-methoxy-3-(4-phenylpiperidin-1-yl)quinoxaline;4-methoxy-1-piperidin-1-ylisoquinoline;2-methoxy-3-piperidin-1-ylquinoxaline;2-methoxyquinoxaline;2-methoxy-3-thiophen-2-ylquinoxaline
C157H158ClF3N28O12S2 — CID 158411834
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-(1-benzothiophen-3-yl)ethyl]-3-methoxyquinoxaline;8-chloro-4-methoxy-7-methyl-2-(trifluoromethyl)quinazoline;2,3-dimethoxyquinoxaline;2-(3,5-dimethylpyrazol-1-yl)-3-methoxyquinoxaline;2-methoxy-3-[(4-methylpiperazin-1-yl)methyl]quinoxaline;2-methoxy-3-(2-phenylethyl)quinoxaline;2-methoxy-3-(4-phenylpiperidin-1-yl)quinoxaline;4-methoxy-1-piperidin-1-ylisoquinoline;2-methoxy-3-piperidin-1-ylquinoxaline;2-methoxyquinoxaline;2-methoxy-3-thiophen-2-ylquinoxaline
2-[2-(1-benzothiophen-3-yl)ethyl]-3-methoxyquinoxaline;8-chloro-4-methoxy-7-methyl-2-(trifluoromethyl)quinazoline;2,3-dimethoxyquinoxaline;2-(3,5-dimethylpyrazol-1-yl)-3-methoxyquinoxaline;2-methoxy-3-[(4-methylpiperazin-1-yl)methyl]quinoxaline;2-methoxy-3-(2-phenylethyl)quinoxaline;2-methoxy-3-(4-phenylpiperidin-1-yl)quinoxaline;4-methoxy-1-piperidin-1-ylisoquinoline;2-methoxy-3-piperidin-1-ylquinoxaline;2-methoxyquinoxaline;2-methoxy-3-thiophen-2-ylquinoxaline (PubChem CID 158411834) has the molecular formula C157H158ClF3N28O12S2 and a molecular weight of 2785.76 g/mol. Its IUPAC name is 2-[2-(1-benzothiophen-3-yl)ethyl]-3-methoxyquinoxaline;8-chloro-4-methoxy-7-methyl-2-(trifluoromethyl)quinazoline;2,3-dimethoxyquinoxaline;2-(3,5-dimethylpyrazol-1-yl)-3-methoxyquinoxaline;2-methoxy-3-[(4-methylpiperazin-1-yl)methyl]quinoxaline;2-methoxy-3-(2-phenylethyl)quinoxaline;2-methoxy-3-(4-phenylpiperidin-1-yl)quinoxaline;4-methoxy-1-piperidin-1-ylisoquinoline;2-methoxy-3-piperidin-1-ylquinoxaline;2-methoxyquinoxaline;2-methoxy-3-thiophen-2-ylquinoxaline.
Molecular Properties
| Compound Name | 2-[2-(1-benzothiophen-3-yl)ethyl]-3-methoxyquinoxaline;8-chloro-4-methoxy-7-methyl-2-(trifluoromethyl)quinazoline;2,3-dimethoxyquinoxaline;2-(3,5-dimethylpyrazol-1-yl)-3-methoxyquinoxaline;2-methoxy-3-[(4-methylpiperazin-1-yl)methyl]quinoxaline;2-methoxy-3-(2-phenylethyl)quinoxaline;2-methoxy-3-(4-phenylpiperidin-1-yl)quinoxaline;4-methoxy-1-piperidin-1-ylisoquinoline;2-methoxy-3-piperidin-1-ylquinoxaline;2-methoxyquinoxaline;2-methoxy-3-thiophen-2-ylquinoxaline |
|---|---|
| PubChem CID | 158411834 |
| Molecular Formula | C157H158ClF3N28O12S2 |
| Molecular Weight | 2785.76 g/mol |
| Exact Mass | 2783.17 |
| IUPAC Name | 2-[2-(1-benzothiophen-3-yl)ethyl]-3-methoxyquinoxaline;8-chloro-4-methoxy-7-methyl-2-(trifluoromethyl)quinazoline;2,3-dimethoxyquinoxaline;2-(3,5-dimethylpyrazol-1-yl)-3-methoxyquinoxaline;2-methoxy-3-[(4-methylpiperazin-1-yl)methyl]quinoxaline;2-methoxy-3-(2-phenylethyl)quinoxaline;2-methoxy-3-(4-phenylpiperidin-1-yl)quinoxaline;4-methoxy-1-piperidin-1-ylisoquinoline;2-methoxy-3-piperidin-1-ylquinoxaline;2-methoxyquinoxaline;2-methoxy-3-thiophen-2-ylquinoxaline |
| SMILES | COc1cnc(N2CCCCC2)c2ccccc12.COc1cnc2ccccc2n1.COc1nc(C(F)(F)F)nc2c(Cl)c(C)ccc12.COc1nc2ccccc2nc1-c1cccs1.COc1nc2ccccc2nc1-n1nc(C)cc1C.COc1nc2ccccc2nc1CCc1ccccc1.COc1nc2ccccc2nc1CCc1csc2ccccc12.COc1nc2ccccc2nc1CN1CCN(C)CC1.COc1nc2ccccc2nc1N1CCC(c2ccccc2)CC1.COc1nc2ccccc2nc1N1CCCCC1.COc1nc2ccccc2nc1OC |
| InChI | InChI=1S/C20H21N3O.C19H16N2OS.C17H16N2O.C15H20N4O.C15H18N2O.C14H14N4O.C14H17N3O.C13H10N2OS.C11H8ClF3N2O.C10H10N2O2.C9H8N2O/c1-24-20-19(21-17-9-5-6-10-18(17)22-20)23-13-11-16(12-14-23)15-7-3-2-4-8-15;1-22-19-17(20-15-7-3-4-8-16(15)21-19)11-10-13-12-23-18-9-5-2-6-14(13)18;1-20-17-16(12-11-13-7-3-2-4-8-13)18-14-9-5-6-10-15(14)19-17;1-18-7-9-19(10-8-18)11-14-15(20-2)17-13-6-4-3-5-12(13)16-14;1-18-14-11-16-15(17-9-5-2-6-10-17)13-8-4-3-7-12(13)14;1-9-8-10(2)18(17-9)13-14(19-3)16-12-7-5-4-6-11(12)15-13;1-18-14-13(17-9-5-2-6-10-17)15-11-7-3-4-8-12(11)16-14;1-16-13-12(11-7-4-8-17-11)14-9-5-2-3-6-10(9)15-13;1-5-3-4-6-8(7(5)12)16-10(11(13,14)15)17-9(6)18-2;1-13-9-10(14-2)12-8-6-4-3-5-7(8)11-9;1-12-9-6-10-7-4-2-3-5-8(7)11-9/h2-10,16H,11-14H2,1H3;2-9,12H,10-11H2,1H3;2-10H,11-12H2,1H3;3-6H,7-11H2,1-2H3;3-4,7-8,11H,2,5-6,9-10H2,1H3;4-8H,1-3H3;3-4,7-8H,2,5-6,9-10H2,1H3;2-8H,1H3;3-4H,1-2H3;3-6H,1-2H3;2-6H,1H3 |
| InChIKey | GZKIQBVSIFRWKN-UHFFFAOYSA-N |
| XLogP | 32.04 |
| TPSA | 415.47 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 42 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 203 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2785.76 |
| LogP ≤ 5 | 32.04 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 42 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158411834 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.